Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy

Bibliographic Details
Main Authors:	Xiyun Deng, Chanjuan Zheng, Faqing Tang, Thomas J. Rosol, Zhi-Ming Shao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	triple-negative breast cancer heterogeneity tumor microenvironment targeted therapy clinical outcomes
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1026566/full

Similar Items

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
by: Si-Yuan Zhu, et al.
Published: (2021-09-01)

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer
by: Ke Jiang, et al.
Published: (2021-03-01)

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers
by: Yiduo Liu, et al.
Published: (2021-05-01)

Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
by: Chanjuan Zheng, et al.
Published: (2023-07-01)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
by: Won-Ji Ryu, et al.
Published: (2021-09-01)

Comprehensive analysis of glycolysis mediated pattern clusters and immune infiltration characterization of tumor microenvironment in triple-negative breast cancer
by: Ji Liu, et al.
Published: (2023-04-01)

Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer
by: Han Gong, et al.
Published: (2024-01-01)

Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
by: Christiana Neophytou, et al.
Published: (2018-02-01)

Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01)

Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
by: Xupeng Bai, et al.
Published: (2021-09-01)

Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
by: Desh Deepak Singh, et al.
Published: (2024-12-01)

Development of a CD8+ T cell-based molecular classification for predicting prognosis and heterogeneity in triple-negative breast cancer by integrated analysis of single-cell and bulk RNA-sequencing
by: Yin-wei Dai, et al.
Published: (2023-09-01)

The advance of adjuvant treatment for triple-negative breast cancer
by: Jingyu Ge, et al.
Published: (2022-02-01)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
by: Ji Liu, et al.
Published: (2022-08-01)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
by: Ying Li, et al.
Published: (2021-10-01)

Assay‐agnostic spatial profiling detects tumor microenvironment signatures: new diagnostic insights for triple‐negative breast cancer
by: Colleen Ziegler, et al.
Published: (2023-10-01)

Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer
by: Gu F, et al.
Published: (2022-09-01)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
by: Fleisher B, et al.
Published: (2016-10-01)

Recent advances in targeted strategies for triple-negative breast cancer
by: Shuangli Zhu, et al.
Published: (2023-08-01)

Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
by: Xi′e Hu, et al.
Published: (2023-03-01)

Programmed cell death-related prognostic genes mediate dysregulation of the immune microenvironment in triple-negative breast cancer
by: Xiaowen Ma, et al.
Published: (2025-03-01)

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
by: Ming Li, et al.
Published: (2018-01-01)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
by: Ángela Quintana, et al.
Published: (2023-05-01)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
by: Jia-Han Ding, et al.
Published: (2022-03-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
by: Sotiris Loizides, et al.
Published: (2023-01-01)

Components of the tumor immune microenvironment based on m‐IHC correlate with prognosis and subtype of triple‐negative breast cancer
by: Luyi Lin, et al.
Published: (2023-12-01)

Heterogeneity derived from 18F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients
by: Yizhao Xie, et al.
Published: (2022-05-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
by: Meng Wang, et al.
Published: (2021-10-01)

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
by: Lucía Serrano García, et al.
Published: (2024-12-01)

RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer
by: Tingjun Li, et al.
Published: (2024-10-01)

Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer
by: Mazharul Haque, et al.
Published: (2024-10-01)

A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01)

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
by: Andras G. Lacko, et al.
Published: (2013-06-01)

Bio-Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment
by: Mahsa Keihan Shokooh, et al.
Published: (2021-02-01)

Advances in immunotherapy for triple-negative breast cancer
by: Yang Liu, et al.
Published: (2023-09-01)

Targeting tumor–stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model
by: Stephanie J. Hachey, et al.
Published: (2024-01-01)

Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
by: Gang Wang, et al.
Published: (2023-05-01)

Recent advances in therapeutic strategies for triple-negative breast cancer
by: Yun Li, et al.
Published: (2022-08-01)

New research advances and future prospect in precision treatment of triple-negative breast cancer
by: XIAO Yuling, ZHU Xiuzhi, JIANG Yizhou, SHAO Zhimin
Published: (2022-08-01)